HMCN1 and nonpapillary renal cell carcinoma: The present study found that key pathways altered in HMCN1-mutant ccRCC samples were oxidative phosphorylation and glucose and lipid metabolism, suggesting that drugs targeted at lipid and glucose metabolism and oxidative phosphorylation might contribute to developing new therapeutic strategies for ccRCC with HMCN1 mutation.